Type 2 diabetes

Venkatasubramaniam, A. ., Mateen, B. A., Shields, B. M., Hattersley, A. T., Jones, A. G., Vollmer, S. J., & Dennis, J. M. (2023). Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine. BMC Med Inform Decis Mak, 23, 110. http://doi.org/10.1186/s12911-023-02207-2
Davies, M. J., Alibegovic, A. C., Jensen, A. B., Munikrishnappa, R. ., Nordsborg, R. B., & Braae, U. C. (2023). Real-world study of ethnic differences in glycaemic control and clinical characteristics among insulin-naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England. Diabetes Obes Metab. http://doi.org/10.1111/dom.15165
Raslan, A. S., Quint, J. K., & Cook, S. . (2023). All-Cause, Cardiovascular and Respiratory Mortality in People with Type 2 Diabetes and Chronic Obstructive Pulmonary Disease (COPD) in England: A Cohort Study Using the Clinical Practice Research Datalink (CPRD). Int J Chron Obstruct Pulmon Dis, 18, 1207–1218. http://doi.org/10.2147/copd.s407085
Larose, S. ., Filliter, C. ., Platt, R. W., H. Y. Yu, O. ., & Filion, K. B. (2023). Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15106
Jeffery, A. ., Bhanu, C. ., Walters, K. ., Wong, I. C., Osborn, D. ., & Hayes, J. F. (2023). Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data. Br J Gen Pract, 73, e392-e398. http://doi.org/10.3399/bjgp.2022.0295
Lai, H. T. M., Chang, K. ., Sharabiani, M. T. A., Valabhji, J. ., Gregg, E. W., Middleton, L. ., … Vamos, E. P. (2023). Twenty-year trajectories of cardio-metabolic factors among people with type 2 diabetes by dementia status in England: a retrospective cohort study. Eur J Epidemiol. http://doi.org/10.1007/s10654-023-00977-7
Islam, N. ., Reynier, P. ., Douros, A. ., H. Y. Yu, O. ., & Filion, K. B. (2023). Sulfonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: a population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.15000
Ling, S. ., Zaccardi, F. ., Issa, E. ., Davies, M. J., Khunti, K. ., & Brown, K. . (2023). Inequalities in cancer mortality trends in people with type 2 diabetes: 20 year population-based study in England. Diabetologia. http://doi.org/10.1007/s00125-022-05854-8
von Arx, L. B., Rachman, J. ., Webb, J. ., Casey, C. ., Patel, A. ., Diomatari, C. ., … Idris, I. . (2023). Therapeutic inertia related to the injectable glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in patients with type 2 diabetes in UK primary care. Diabetes Obes Metab. http://doi.org/10.1111/dom.14985
group, D. working. (2022). Estimating individual lifetime risk of incident cardiovascular events in adults with type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2). Eur J Prev Cardiol. http://doi.org/10.1093/eurjpc/zwac232